Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and identical protein binding activity. Acts upstream of or within several processes, including defense response to bacterium; macrophage differentiation; and phagocytosis. Predicted to be located in nucleus. Is expressed in bone marrow; liver; lung; and spleen. Orthologous to human CEBPE (CCAAT enhancer binding protein epsilon). [provided by Alliance of Genome Resources, Apr 2022]